Cancer

Cannabis use among cancer patients is lower than that of the general public, with just 9% of cancer patients having used cannabis compared to 14% of people with no cancer history according to a new study.

The United Kingdom National Health Service and Brain Tumour Charity are partnering on research to determine whether cannabis-based medicine Sativex paired with chemotherapy medication temozolomide can treat glioblastoma.

A new study published last week in Gynecologic Oncology Reports found 71% of gynecologic cancer patients reported self-improvement while using medical cannabis.

The Texas House approved expansions to the state’s medical cannabis program that would raise the THC limit from 0.5% to 5% and legalize access for patients with chronic pain, PTSD, and cancer.

Australian researchers found a 14-25 percent reduction in chemotherapy side effects in patients who received cannabis capsules during a recent study.

Government-backed researchers in Thailand found in a series of test tube studies that cannabis extracts may inhibit cancer cell growth.

Harvard researchers recently identified a specific cannabis flavonoid that was able to kill tumor cells in 70 percent of mice with pancreatic cancer.

Medical cannabis patients in Minnesota have reported a “significant reduction” in the severity of their cancer symptoms.

The study hopes to correct a lack of double-blind, placebo-controlled studies regarding cannabis’ effects on cancer symptoms.